Comparison of case-based learning and traditional method in teaching postgraduate students of medical oncology von Bi, Minghong, Zhao, Zhibiao, Yang, Jingru, Wang, Yaping

Volltext

Equivalent efficacy study of QL1101 and bevacizumab on untreated advanced non-squamous non-small cell lung cancer patients: a phase 3 randomized, double-blind clinical trial von Chu, Tianqing, Lu, Jun, Bi, Minghong, Zhang, Helong, Zhuang, Wu, Yu, Yan, Shi, Jianhua, Chen, Zhendong, Zhang, Xiaochun, Guo, Qisen, Liu, Quan, Wu, Huijuan, Fang, Jian, Hu, Yi, Wang, Xiuwen, Han, Cuicui, Li, Kai, Han, Baohui

Volltext

Prognostic values of inflammatory indexes in bevacizumab-treated patients with advanced non-small-cell lung cancer von Yang, Jingru, Deng, Mingliang, Bi, Minghong, Wang, Yaping, Qiao, Xuxu, Zhang, Shanshan

Volltext

Bevacizumab biosimilar LY01008 compared with bevacizumab (Avastin) as first‐line treatment for Chinese patients with unresectable, metastatic, or recurrent non‐squamous non–small‐c... von Shi, Yuankai, Lei, Kaijian, Jia, Yuming, Ni, Bingqiang, He, Zhiyong, Bi, Minghong, Wang, Xicheng, Shi, Jianhua, Zhou, Ming, Sun, Qian, Wang, Guolei, Chen, Dongji, Shu, Yongqian, Liu, Lianke, Guo, Zhongliang, Liu, Yong, Yang, Junquan, Wang, Ke, Xiao, Ke, Wu, Lin, Yi, Tienan, Sun, Debin, Kang, Mafei, Ma, Tianjiang, Mao, Yimin, Shi, Jinsheng, Tang, Tiegang, Wang, Yan, Xing, Puyuan, Lv, Dongqing, Liao, Wangjun, Luo, Zhiguo, Wang, Bin, Wu, Xiaohong, Zhu, Xiaoli, Han, Shuhua, Guo, Qisen, Liu, Rongyu, Lu, Zhiwei, Zhang, Jianyong, Fang, Jian, Hu, Changlu, Ji, Yinghua, Liu, Guolong, Lu, Hong, Wu, Dedong, Zhang, Junhong, Zhu, Shuyang, Liu, Zheng, Qiu, Wensheng, Ye, Feng, Yu, Yan, Zhao, Yanqiu, Zheng, Qinhong, Chen, Jun, Pan, Zhanyu, Zhang, Yiping, Lian, Wenjuan, Jiang, Bo, Qiu, Bo, Zhang, Guojun, Zhang, Hua, Chen, Yanju, Chen, Yuan, Duan, Hongbing, Li, Manxiang, Liu, Shengming, Ma, Lijun, Pan, Hongming, Yuan, Xia, Yuan, Xueli, Zheng, Yulong, Gao, Emei, Zhao, Li, Wang, Shumin, Wu, Can

Volltext

Influence of concomitant gastric acid suppressants use on the survival of patients with non-small cell lung cancer treated with programmed death-1/ligand-1 inhibitors: A meta-analy... von Wang, Mingyu, Lu, Depeng, Bi, Minghong

Volltext

The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis von Zhang, Shanshan, Bi, Minghong

Volltext

Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: a Randomized, Double-Blind, Phase 3 Stu... von Yang, Yunpeng, Wang, Zhehai, Fang, Jian, Yu, Qitao, Han, Baohui, Cang, Shundong, Chen, Gongyan, Mei, Xiaodong, Yang, Zhixiong, Ma, Rui, Bi, Minghong, Ren, Xiubao, Zhou, Jianying, Li, Baolan, Song, Yong, Feng, Jifeng, Li, Juan, He, Zhiyong, Zhou, Rui, Li, Weimin, Lu, You, Wang, Yingyi, Wang, Lijun, Yang, Nong, Zhang, Yan, Yu, Zhuang, Zhao, Yanqiu, Xie, Conghua, Cheng, Ying, Zhou, Hui, Wang, Shuyan, Zhu, Donglei, Zhang, Wen, Zhang, Li

Volltext

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phas... von Paz-Ares, Luis, Dvorkin, Mikhail, Chen, Yuanbin, Reinmuth, Niels, Hotta, Katsuyuki, Hochmair, Maximilian J, Özgüroğlu, Mustafa, Ji, Jun Ho, Bondarenko, Igor, Byrne, Natalie, Shire, Norah, Goldman, Jonathan W, Batagelj, Emilio, Casarini, Ignacio, Pastor, Anea Viviana, Hartl, Sylvia, Hochmair, Maximilian J, Lamprecht, Bernd, Dos Reis, Peo, Serodio da Rocha Baldotto, Clarissa, Venkova, Violetka, Bi, Minghong, Chen, Zhendong, Han, Zhigang, Hu, Yi, Li, Wei, Ma, Shenglin, Nan, Kejun, Shu, Yongqian, Wang, Kai, Yang, Nong, Zhang, Wei, Zhao, Jun, Zhao, Yanqiu, Zhou, Caicun, Zhou, Xiangdong, Skrickova, Jana, Hilgers, Werner, Moro-Sibilot, Denis, Bischoff, Helge, Lang, Susanne, Fülöp, Anea, Horváth, Zsolt, Laczó, Ibolya, Losonczy, György, Pápai Székely, Zsolt, Telekes, Anás, Bar, Jair, Gottfried, Maya, Heching, Norman Isaac, Bettini, Anna Cecilia, Minelli, Mauro, Roila, Fausto, Verderame, Francesco, Atagi, Shinji, Goto, Hisatsugu, Goto, Koichi, Hara, Yu, Hida, Toyoaki, Hotta, Katsuyuki, Kuyama, Shoichi, Morise, Masahiro, Nakahara, Yasuharu, Okamoto, Isamu, Shinoda, Masahiro, Umemura, Shigeki, Heniks, Lizza, Ungureanu, Anei, Luft, Alexander, Sakaeva, Dina, Smolin, Alexey, Statsenko, Galina, Vasilyev, Alexander, Vladimirova, Lyubov, Chovanec, Jozef, Urda, Michal, Ji, Jun Ho, Lee, Kyung Hee, Isla Casado, Dolores, Ponce Aix, Santiago, Hsia, Te-Chun, Wu, Shang-Yin, Çiçin, Irfan, Göksel, Tuncay, Özgüroğlu, Mustafa, Adamchuk, Hryhoriy, Bondarenko, Igor, Kryzhanivska, Anna, Shevnia, Serhii, Trukhin, Dmytro, Ursol, Grygorii, Voitko, Oleksandr, Vynnychenko, Ihor, Chen, Yuanbin, Chua, Winston, Dakhil, Shaker, Goldman, Jonathan W, Lakhanpal, Shailena, Powell, Steven, Stilwill, Joseph

Volltext

Downregulation of NEAT1 Suppresses Cell Proliferation, Migration, and Invasion in NSCLC Via Sponging miR-153-3p von Zhao, Lun, Bi, Minghong, Zhang, Haoran, Shi, Mohan

Volltext

Clinical meaning of EML4-ALK fusion gene in non-small cell lung cancer von Han, Wei, Bi, Minghong

Volltext

Updated Overall Survival Data and Predictive Biomarkers of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC in t... von Yang, Yunpeng, Sun, Jiya, Wang, Zhehai, Fang, Jian, Yu, Qitao, Han, Baohui, Cang, Shundong, Chen, Gongyan, Mei, Xiaodong, Yang, Zhixiong, Ma, Rui, Bi, Minghong, Ren, Xiubao, Zhou, Jianying, Li, Baolan, Song, Yong, Feng, Jifeng, Li, Juan, He, Zhiyong, Zhou, Rui, Li, Weimin, Lu, You, Zhou, Hui, Wang, Shuyan, Sun, Luyao, Puig, Oscar, Mancao, Christoph, Peng, Bo, Fang, Wenfeng, Xu, Wei, Zhang, Li

Volltext

Activity and Safety of Geptanolimab (GB226) for Patients with Unresectable, Recurrent, or Metastatic Alveolar Soft Part Sarcoma: A Phase II, Single-arm Study von Shi, Yuankai, Cai, Qiqing, Jiang, Yu, Huang, Gang, Bi, Minghong, Wang, Baocheng, Zhou, Yuhong, Wang, Guowen, Ying, Hongyan, Tao, Zhiwei, Shi, Chunmei, Guo, Qian, Gao, Chao

Volltext

Phase Ib/IIa study assessing the safety and efficacy of AL8326 monotherapy in patients with ≥3rd line small cell lung cancer (SCLC) treatment von Zhang, Xiaochun, Li, Xingya, Bi, Minghong, Su, Chunxia, Fang, Yong, WANG, Zibing, Yuan, Ying, Du, Xiuping, Lv, Tangfeng, Li, Yingyin

Volltext

Efficacy and safety of second-line camrelizumab combined with apatinib and chemotherapy in patients with advanced lung adenocarcinoma: A prospective, open-label, multicentric study von Yao, Yiwei, Wang, Yong, Du, Yingying, Jiang, Fengshou, Liang, Hui, Bi, Minghong, Xie, Hua, Peng, Wanren, Pan, Yueyin

Volltext

A real-world study of camrelizumab in the treatment of advanced lung cancer patients von Gu, Kangsheng, Bi, Minghong, Zhao, Dong, Cheng, Huaidong, Wang, Genhe, Qian, Hong, Min, Xuhong, Xia, Xiaoyang, Wang, Fan, Hu, Zhiqiang

Volltext

A clinical study of camrelizumab combined with chemotherapy and sequential apatinib in the second-line treatment of patients with advanced non-small cell lung cancer von Pan, Yueyin, Jiang, Fengshou, Du, Yingying, Wang, Yong, Liu, Hu, Wang, Zishu, Liang, Hui, Bi, Minghong, Yao, Yiwei

Volltext

Research progress of HGF/MET signaling pathway in EGFR-TKI resistance 
in non-small cell lung cancer von Song, Shilong, Bi, Minghong

Volltext

Denosumab biosimilar (LY01011) in the treatment of bone metastases in patients with solid tumors: A multicenter, randomized, double-blind, active comparator-controlled phase 3 stud... von Zhao, Mingchuan, Hu, Xichun, Zeng, Aiping, Yu, Yan, Shi, Huaqiu, Chen, Zhendong, Sun, Hongmei, Yang, Weihua, Sheng, Lili, Peng, Peijian, Wang, Jingfen, Yi, Tienan, Bi, Minghong, Ni, Mingli, Dai, Xiumei, Hu, Changlu, Lei, Kaijian, Yuan, Xia, Li, Qingshan, Lv, Dongqing

Volltext

A multicenter, randomized, double-blind, phase III trial comparing denosumab biosimilar QL1206 and denosumab in patients with bone metastases from solid tumors von Li, Huiping, Huang, Yan, Zhang, Li, Chen, Zhendong, Zeng, Aiping, Zhang, Helong, Yu, Yan, Wei, Shihong, Li, Qingshan, Wang, Xiaojia, Wang, Xiangcai, Wang, Xiuwen, Yang, Runxiang, Dai, Xiumei, Bi, Minghong, Sun, Tao, Zhang, Qingyuan, Han, Cuicui, Liu, Qianqian, Li, Yujie

Volltext

Efficacy and Safety of Rezivertinib (BPI-7711) in Patients With Locally Advanced or Metastatic/Recurrent EGFR T790M-Mutated NSCLC: A Phase 2b Study von Shi, Yuankai, Wu, Shiman, Wang, Ke, Cang, Shundong, Yao, Wenxiu, Fan, Yun, Wu, Lin, Huang, Meijuan, Li, Xingya, Pan, Yueyin, Yang, Zhixiong, Zhu, Bo, Chen, Gongyan, Shi, Jianhua, Sun, Meili, Fang, Jian, Wang, Lijun, Chen, Zhaohong, Liu, Chunling, Li, Jingzhang, Liu, Jiwei, Sun, Shenghua, Zhao, Yanqiu, Guo, Yanzhen, Meng, Zili, Liu, Zhefeng, Han, Zhigang, Lu, Hong, Ma, Rui, Hu, Sheng, Zhao, Guofang, Liu, Zheng, Xie, Congying, Zhong, Diansheng, Zhao, Hui, Yu, Huiqing, Zhang, Longzhen, Bi, Minghong, Yi, Shanyong, Guo, Shuliang, Yi, Tienan, Li, Wen, Lin, Yingcheng, Shu, Yongqian, Chen, Zhendong, Guo, Zhongliang, Greco, Michael, Wang, Tingting, Shen, Haijiao

Volltext